Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents
出版年份 2012 全文链接
标题
Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents
作者
关键词
-
出版物
JOURNAL OF VIRAL HEPATITIS
Volume 19, Issue 7, Pages 449-464
出版商
Wiley
发表日期
2012-06-08
DOI
10.1111/j.1365-2893.2012.01617.x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006
- (2011) Ian T. Williams et al. ARCHIVES OF INTERNAL MEDICINE
- Inosine Triphosphate Protects Against Ribavirin-Induced Adenosine Triphosphate Loss by Adenylosuccinate Synthase Function
- (2011) Yuki Hitomi et al. GASTROENTEROLOGY
- Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients
- (2011) Frank Wagner et al. HEPATOLOGY
- 66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R
- (2011) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- 60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
- (2011) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- 1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335
- (2011) R. Sane et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies
- (2010) Paul J Clark et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
- (2010) Ira M. Jacobson et al. Clinical Gastroenterology and Hepatology
- Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
- (2010) Alexander J. Thompson et al. HEPATOLOGY
- Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study
- (2010) Nicole Forestier et al. JOURNAL OF HEPATOLOGY
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
- (2010) Lotte Coelmont et al. PLoS One
- Review: Hepatitis C virus replication and potential targets for direct-acting agents
- (2010) Jacqueline G. O'Leary et al. Therapeutic Advances in Gastroenterology
- Review: New direct-acting antivirals in the development for hepatitis C virus infection
- (2010) Paul J. Pockros Therapeutic Advances in Gastroenterology
- Hepatitis C virus experimental model systems and antiviral drug research
- (2010) Susan L. Uprichard VIROLOGICA SINICA
- MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
- (2009) N. J. Liverton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- Antiviral resistance and specifically targeted therapy for HCV (STAT-C)
- (2009) A. J. V. Thompson et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B and hepatitis C in 2009
- (2009) Patrick Marcellin LIVER INTERNATIONAL
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors
- (2008) M. F. McCown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early steps of the hepatitis C virus life cycle
- (2008) Jean Dubuisson et al. CELLULAR MICROBIOLOGY
- Novel Hepatitis C Drugs in Current Trials
- (2008) Bernd Kronenberger et al. Clinics in Liver Disease
- Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein
- (2008) Timothy L. Tellinghuisen et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now